Disc Medicine, Inc.
IRON
Rank in Stocks
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Share Price
$75.39
Last synced: 2026-10-22
Market Cap
$2.89B
Change (1 day)
-0.80%
Change (1 year)
-9.92%
Country
US
Trade Disc Medicine, Inc. (IRON)
Category
Healthcare
P/B ratio for Disc Medicine, Inc. (IRON)
P/B ratio as of October 2026 TTM: 4.65
According to Disc Medicine, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 4.65. At the end of 2024 the company had a P/B ratio of 3.95.
P/B ratio history for Disc Medicine, Inc. from 2020 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 4.65 | 22.73% |
| 2025 | 3.79 | -3.98% |
| 2024 | 3.95 | 5.64% |
| 2023 | 3.73 | 3,089.41% |
| 2022 | 0.12 | -132.23% |
| 2021 | -0.36 | -95.22% |
| 2020 | -7.61 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 6.6964 | 43.96% |
US
|
|
| 13.6307 | 193.03% |
US
|
|
| 4.4521 | -4.29% |
AU
|
|
| 4.2241 | -9.19% |
BE
|
|
| 6.3632 | 36.80% |
NL
|
